111 – 120 of 149
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
From gamma-carboxy-glutamate to protein C.
(
- Contribution to journal › Article
-
Mark
The von Willebrand disease prophylaxis network: exploring a treatment concept.
(
- Contribution to journal › Article
-
Mark
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD
(
- Contribution to journal › Article
-
Mark
Are randomized clinical trials the only truth? Not always
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The cleaved and latent forms of antithrombin are normal constituents of blood plasma: a quantitative method to measure cleaved antithrombin.
(
- Contribution to journal › Article
-
Mark
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
(
- Contribution to journal › Scientific review
-
Mark
Potential role of rFVIIa in prophylaxis in severe haemophilia patients with inhibitors.
(
- Contribution to journal › Article
-
Mark
The natural course of women with recurrent fetal loss
(
- Contribution to journal › Article
- 2005
-
Mark
Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma.
(
- Contribution to journal › Article
-
Mark
Post-translational modifications in proteins involved in blood coagulation.
(
- Contribution to journal › Scientific review